George Clinical is leading the way in clinical research alongside its parent company, The George Institute for Global Health, a leader in chronic disease research. Clinical research is a dynamic industry, constantly evolving thanks to technological advances such asreal-time data collection and analysis, health care applications, and wearable technologies. The clinical trial industry is making tremendous strides thanks to these digital and technological advances; making studies more efficient, safer, and garnering more participants.

How Real Time Data Collection Works

As technology improves, so do all areas that are impacted by them. Clinical trials are no exception. The industry is constantly impacted by improvements in real-time data collection and electronic data capture systems, for example. Electronic data capture allows for less in-clinic visits, and real-time data collection allows researchers to continually collate data during a study rather than having to wait until after data collection has concluded before undertaking the data review process. This means that data can be analyzed during a trial, allowing for any issues to be identified earlier and changes can be made if necessary. The benefits of these technological advances include greater efficiency, safer trials for participants, accelerated drug development, and ultimately helping patients sooner. It also helps to reduce the cost of the clinical trial, saving trial sponsors money. Digital collection also helps improve the accuracy of reporting since it can identify and eliminate human errors, which is always a risk in any trial.

How Mobile Health Applications Advance Clinical Trials

Wearables and mobile health applications are relatively new technologies that have the potential to make a significant impact on clinical trials. Wearables are the new market of devices that monitor movement, vitals, and other health metrics. Health applications are available on smartphones and combine user entered data with monitoring metrics. As you can imagine, this means even less of a need for participants to go to clinics for in-house trials. A bonus is that the metrics can be continually collected rather than just during an in-clinic visit. Certain applications even allow users to just “opt-in” anonymously, and that is bringing about a huge increase in participants. The greater the participationthe more compelling the results.

Technology is also encouraging more clinical trial participation in other ways. Mobile applications and wearable devices are making it even easier for people to participate in clinical studies and reporting is potentially taken care of by the wearable devices that can monitor vitals, movement, and other health metrics and report them automatically and on an ongoing basis. As the wearable and healthcare app industry grows, the potential for clinical trials using them has the potential to increase in tandem.

In 2015, Apple launched a new Apple Watch application called The Research Kit. It comes standard with all Apple Watches. It allows users to download clinical trial applications directly from the application and uses the watch to measure metrics. This means that many more people are exposed to learning about participating in clinical trials.

Inevitably, however, when scientific integrity and regulatory conformity is of paramount importance, there is still a long way to go before wearables become the ‘panacea’ for smart and efficient trial delivery. Wearables still present considerable hurdles in the data collection process. Critical questions such as: are the devices being used correctly? Is the participant wearing the device at all times and not giving them to a friend? Is the technology free from external interference, such as hackers? Until all these questions (and many others) are answered and the data integrity ensured, they will remain just an excitingfuture prospect instead of a current reality.

Conclusion and Takeaways

Technology is certainly improving the clinical trial and research industry as a whole. The collection and evaluation of data in real time is helping to improve the process in many ways, while also make clinical trial participation easier and more appealing. As a result, clinical trial data collection continues to be improvedas larger populations elect to participate in a trial.

Companies like George Clinical that specialize in clinical trial research are prepared to embrace new technologies. They are already at the forefront of clinical data collection esystems and are accredited with leading platforms such as Medidata Rave, Merge eClinical and Medrio. They are constantly on the lookout for technological advances that improve the trial delivery process, yet maintain the highest scientific standards. Rather than rejecting the new appeal for mobile applications and wearables outright, the industry should work with the innovators of these new wearable technologies in order to ensure that critical questions regarding data integrity and the highest scientific standards are answered in order to improve the health care opportunities for people all over the world.

http://www.dailynewsz.com/wp-content/uploads/2017/02/Technological-Advances-Improving-Clinical-Trial-Performance.pnghttp://www.dailynewsz.com/wp-content/uploads/2017/02/Technological-Advances-Improving-Clinical-Trial-Performance-300x300.pngAdminHealthTechnologyclinical trial,data collection
George Clinical is leading the way in clinical research alongside its parent company, The George Institute for Global Health, a leader in chronic disease research. Clinical research is a dynamic industry, constantly evolving thanks to technological advances such asreal-time data collection and analysis, health care applications, and wearable technologies....